I'd be happy with a $20USD NASDAQ IPO in December if ZCC had a new CEO in place.

You can't compare the stock prices of two companies without looking at market cap. Repare's market cap is $450 million.  With Zenith's current  ~150,000,000 shares outstanding, that's a $3 price for Zenith if the two companies had the same market cap.

A Nasdaq IPO at $20 US?  OK.  But what would be the price of our shares after the dust settles?  Just a small fraction of $20.  We'd be on the receiving end of a massive reverse split in order to do that IPO.

Anyhow, this is all reminiscing about what could/might/should have been.  We are where we are today.  There's nothing to do but wait for a pharma to do a deal or buy us out.

PS.  Would somebody please remove the spammers.  Thanks.